Pediatric Cardiology News

The disparate prevalence of cardiovascular risk factors among adult Black and Hispanic survivors of childhood cancer was comparable to the disparities in the American general population, researchers reported.

Children who underwent implantation of a transcatheter leadless pacemaker experienced implant success, good electrical performance and a low level of major complications during short-term follow-up, real-world data show.

Primary hypertension is now the leading type of pediatric hypertension, especially in adolescents, raising their subsequent risk for CV events in adulthood, according to a new scientific statement from the American Heart Association.

Elevated umbilical cord blood insulin concentration measured early after birth could be tied to high BP during childhood and adolescence, especially in children born preterm, according to a study published in Hypertension.

Regeneron Pharmaceuticals announced the FDA has extended approval of evinacumab-dgnb as an adjunct to other lipid-lowering therapy for the treatment of homozygous familial hypercholesterolemia in children aged 5 to 11 years.

Among Medicaid-insured youths from Delaware, higher childhood neighborhood area deprivation index score was associated with hypertension diagnosis, researchers reported.

Dexrazoxane appeared to have a cardioprotective effect almost 2 decades after exposure to anthracyclines among a cohort of young adults who survived childhood cancer, according to study results published in Journal of Clinical Oncology.

A large-scale study found that the risk for developing hypertension within 5 years was higher even among children who were at the high end of normal weight, according to findings published in JAMA Network Open.

Haptoglobin gene expression in the blood appeared associated with anthracycline-related cardiomyopathy among childhood cancer survivors, according to study results.

Emerging precision medicine therapies targeting the molecular causes of cardiomyopathy and HF may improve the outlook for pediatric patients with HF, according to a review published in Translational Pediatrics.